Morin and Its Role in Chronic Diseases
Authors:
- 25 September 2016
- book chapter
- Published by Springer Nature
- Vol. 928, 453-471
Abstract
Chronic diseases can be referred to the long-term medical conditions which are mostly progressive in nature, i.e., it deteriorates over time. Diabetes, arthritis, heart disease, stroke, cancer, and chronic respiratory problems (e.g., COPD) are not a few examples of chronic diseases and chronic diseases are the leading causes of death and disability all over the world. Chronic diseases and conditions are among the most common, costly, and preventable of all health problems. Affordable cost, presence mostly in the consumables, and minimal side effects make the naturally occurring compounds interesting and attractive for pharmacological study in recent years. Plants produce diverse types of low molecular weight products mainly for the defense purpose. Among them, the group of secondary metabolites related to a polyphenolic group has been named flavonoids and are of great interest due to their incredible pharmacological properties. In these regard, due to its potent anti-inflammatory, anti-apoptotic and many important pharmacological properties (relevant to chronic diseases, e.g., urate transporter inhibitor related to gout, modulator of immunosystem related to chronic hypersensitivity, etc.), morin [morin hydrate:2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopy ran-4-one; 3,5,7,20,40 pentahydroxyflavone], widely found among the Moraceae family, considered as one of the most important key bioflavonols. However, little is known about the molecular mechanisms of its action on such conditions. In this chapter, we have summarized most of the findings, if not all, available till date.Keywords
This publication has 46 references indexed in Scilit:
- Alleviating effects of morin against experimentally-induced diabetic osteopeniaDiabetology & Metabolic Syndrome, 2013
- Effect of morin, a flavonoid against DOCA-salt hypertensive rats: a dose dependent studyAsian Pacific Journal of Tropical Biomedicine, 2012
- Morin hydrate inhibits amyloid formation by islet amyloid polypeptide and disaggregates amyloid fibersProtein Science, 2012
- Antiarthritic and antioxidant effects of the leaf extract of Ficus exasperata P. Beauv. (Moraceae)Pharmacognosy Research, 2010
- Molecular mechanisms of neuroprotection by two natural antioxidant polyphenolsCell Calcium, 2009
- Fisetin, morin and myricetin attenuate CD36 expression and oxLDL uptake in U937-derived macrophagesBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2008
- The Antiplatelet Effect of Six Non-Steroidal Anti-Inflammatory Drugs and Their Pharmacodynamic Interaction With Aspirin in Healthy VolunteersThe American Journal of Cardiology, 2008
- Morin (3,5,7,2′,4′-Pentahydroxyflavone) Exhibits Potent Inhibitory Actions on Urate Transport by the Human Urate Anion Transporter (hURAT1) Expressed in Human Embryonic Kidney CellsDrug Metabolism and Disposition, 2007
- Transcription Factors in the Cellular Signaling Network as Prime Targets of Chemopreventive PhytochemicalsCancer Research and Treatment, 2004
- Salicylates for ulcerative colitis—their mode of actionPharmacology & Therapeutics, 1994